Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients
Status:
Recruiting
Trial end date:
2024-10-18
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the safety, tolerability, pharmacokinetics and therapeutic
efficacy of treatment with either VAY736 or CFZ533 in patients with SLE to enable further
development of these compounds as treatment in this disease population